For instance, given the high regulation of NOD1/2 by ubiquitin and the contribution of NOD mutations to inflammatory diseases such as inflammatory bowel disease (IBD) or Crohn's disease, it is possible that DUBs could be used as a target in NOD-associated inflammatory conditions. This evidence concerns the gene NOD1 and inflammatory bowel disease.